vs

Side-by-side financial comparison of Penumbra Inc (PEN) and TELEFLEX INC (TFX). Click either name above to swap in a different company.

TELEFLEX INC runs the higher net margin — 177.8% vs 12.3%, a 165.5% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs -150.5%). Penumbra Inc produced more free cash flow last quarter ($68.0M vs $-92.9M). Over the past eight quarters, TELEFLEX INC's revenue compounded faster (NaN% CAGR vs NaN%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with...

PEN vs TFX — Head-to-Head

Bigger by revenue
PEN
PEN
-1.0× larger
PEN
$385.4M
$-401.9M
TFX
Growing faster (revenue YoY)
PEN
PEN
+172.7% gap
PEN
22.1%
-150.5%
TFX
Higher net margin
TFX
TFX
165.5% more per $
TFX
177.8%
12.3%
PEN
More free cash flow
PEN
PEN
$161.0M more FCF
PEN
$68.0M
$-92.9M
TFX
Faster 2-yr revenue CAGR
TFX
TFX
Annualised
TFX
NaN%
17.6%
PEN

Income Statement — Q4 2025 vs Q4 2025

Metric
PEN
PEN
TFX
TFX
Revenue
$385.4M
$-401.9M
Net Profit
$47.3M
$-714.3M
Gross Margin
68.0%
Operating Margin
15.4%
Net Margin
12.3%
177.8%
Revenue YoY
22.1%
-150.5%
Net Profit YoY
40.6%
-422.7%
EPS (diluted)
$1.20
$-15.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PEN
PEN
TFX
TFX
Q4 25
$385.4M
$-401.9M
Q3 25
$354.7M
$913.0M
Q2 25
$339.5M
$780.9M
Q1 25
$324.1M
$700.7M
Q4 24
$315.5M
$795.4M
Q3 24
$301.0M
$764.4M
Q2 24
$299.4M
$749.7M
Q1 24
$278.7M
$737.8M
Net Profit
PEN
PEN
TFX
TFX
Q4 25
$47.3M
$-714.3M
Q3 25
$45.9M
$-408.9M
Q2 25
$45.3M
$122.6M
Q1 25
$39.2M
$95.0M
Q4 24
$33.7M
$-136.7M
Q3 24
$29.5M
$111.0M
Q2 24
$-60.2M
$80.0M
Q1 24
$11.0M
$15.3M
Gross Margin
PEN
PEN
TFX
TFX
Q4 25
68.0%
Q3 25
67.8%
49.5%
Q2 25
66.0%
55.2%
Q1 25
66.6%
55.6%
Q4 24
66.8%
55.3%
Q3 24
66.5%
56.3%
Q2 24
54.4%
55.6%
Q1 24
65.0%
56.4%
Operating Margin
PEN
PEN
TFX
TFX
Q4 25
15.4%
Q3 25
13.8%
-44.8%
Q2 25
12.0%
19.9%
Q1 25
12.4%
17.9%
Q4 24
13.6%
-13.9%
Q3 24
11.7%
19.5%
Q2 24
-27.0%
15.6%
Q1 24
4.3%
-0.6%
Net Margin
PEN
PEN
TFX
TFX
Q4 25
12.3%
177.8%
Q3 25
12.9%
-44.8%
Q2 25
13.3%
15.7%
Q1 25
12.1%
13.6%
Q4 24
10.7%
-17.2%
Q3 24
9.8%
14.5%
Q2 24
-20.1%
10.7%
Q1 24
3.9%
2.1%
EPS (diluted)
PEN
PEN
TFX
TFX
Q4 25
$1.20
$-15.85
Q3 25
$1.17
$-9.24
Q2 25
$1.15
$2.77
Q1 25
$1.00
$2.07
Q4 24
$0.88
$-2.89
Q3 24
$0.75
$2.36
Q2 24
$-1.55
$1.69
Q1 24
$0.28
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PEN
PEN
TFX
TFX
Cash + ST InvestmentsLiquidity on hand
$186.9M
$378.6M
Total DebtLower is stronger
$2.6B
Stockholders' EquityBook value
$1.4B
$3.1B
Total Assets
$1.8B
$6.9B
Debt / EquityLower = less leverage
0.85×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PEN
PEN
TFX
TFX
Q4 25
$186.9M
$378.6M
Q3 25
$321.0M
$354.0M
Q2 25
$421.8M
$253.7M
Q1 25
$376.1M
$284.1M
Q4 24
$324.4M
$290.2M
Q3 24
$280.5M
$243.2M
Q2 24
$288.3M
$238.6M
Q1 24
$223.1M
$237.4M
Total Debt
PEN
PEN
TFX
TFX
Q4 25
$2.6B
Q3 25
$2.7B
Q2 25
$1.9B
Q1 25
$1.9B
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PEN
PEN
TFX
TFX
Q4 25
$1.4B
$3.1B
Q3 25
$1.4B
$3.8B
Q2 25
$1.3B
$4.2B
Q1 25
$1.2B
$4.1B
Q4 24
$1.2B
$4.3B
Q3 24
$1.1B
$4.5B
Q2 24
$1.2B
$4.6B
Q1 24
$1.2B
$4.5B
Total Assets
PEN
PEN
TFX
TFX
Q4 25
$1.8B
$6.9B
Q3 25
$1.7B
$7.9B
Q2 25
$1.7B
$7.4B
Q1 25
$1.6B
$7.2B
Q4 24
$1.5B
$7.1B
Q3 24
$1.5B
$7.5B
Q2 24
$1.5B
$7.4B
Q1 24
$1.6B
$7.5B
Debt / Equity
PEN
PEN
TFX
TFX
Q4 25
0.85×
Q3 25
0.70×
Q2 25
0.45×
Q1 25
0.47×
Q4 24
0.39×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PEN
PEN
TFX
TFX
Operating Cash FlowLast quarter
$86.5M
$-92.3M
Free Cash FlowOCF − Capex
$68.0M
$-92.9M
FCF MarginFCF / Revenue
17.7%
23.1%
Capex IntensityCapex / Revenue
4.8%
-0.2%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M
$1.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PEN
PEN
TFX
TFX
Q4 25
$86.5M
$-92.3M
Q3 25
$58.3M
$107.8M
Q2 25
$44.9M
$7.8M
Q1 25
$49.0M
$73.3M
Q4 24
$51.1M
$202.6M
Q3 24
$56.5M
$231.1M
Q2 24
$22.6M
$91.7M
Q1 24
$38.3M
$112.8M
Free Cash Flow
PEN
PEN
TFX
TFX
Q4 25
$68.0M
$-92.9M
Q3 25
$42.0M
$77.8M
Q2 25
$29.4M
$-26.8M
Q1 25
$35.5M
$43.3M
Q4 24
$45.7M
$170.6M
Q3 24
$51.0M
$209.9M
Q2 24
$18.1M
$56.9M
Q1 24
$32.5M
$74.4M
FCF Margin
PEN
PEN
TFX
TFX
Q4 25
17.7%
23.1%
Q3 25
11.8%
8.5%
Q2 25
8.7%
-3.4%
Q1 25
11.0%
6.2%
Q4 24
14.5%
21.4%
Q3 24
16.9%
27.5%
Q2 24
6.0%
7.6%
Q1 24
11.7%
10.1%
Capex Intensity
PEN
PEN
TFX
TFX
Q4 25
4.8%
-0.2%
Q3 25
4.6%
3.3%
Q2 25
4.6%
4.4%
Q1 25
4.2%
4.3%
Q4 24
1.7%
4.0%
Q3 24
1.8%
2.8%
Q2 24
1.5%
4.6%
Q1 24
2.1%
5.2%
Cash Conversion
PEN
PEN
TFX
TFX
Q4 25
1.83×
Q3 25
1.27×
Q2 25
0.99×
0.06×
Q1 25
1.25×
0.77×
Q4 24
1.52×
Q3 24
1.91×
2.08×
Q2 24
1.15×
Q1 24
3.48×
7.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons